Displaying 205 - 216 items out of 697 results
Press release
… (San Diego, Calif.--September 7, 2024, 8:30 a.m.) — Research presented today suggests an artificial intelligence … mutation prediction from histopathology slides. The research was presented today at the IASLC 2024 World … Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, the First Affiliated …
Press release
… the 2025 Mary J. Matthews Pathology/Translational Research Award. She has contributed to the IASLC WCLC for more … Gomez has conducted landmark clinical and translational research in early-stage , locally advanced , and, … therapy. Dr. Najmeh leads the patient outcomes research team within her division and is actively involved in …
Press release
… Patient perspectives provide context for research advances discussed at the IASLC 2020 North America … issues, clinical trial participation and design, and research endpoints that are meaningful to the lung cancer community. The conference will provide research updates in the forms of data presentations given by …
ILCN article
Food as Medicine: Research Aims to Understand the Power of Nutrition in Treating Cancer
… Cancer Center and the James Cancer Hospital/Solove Research Institute, recently spoke with ILCN about the study … the EORTC QLQ-C30 (the European Organization for the Research and Treatment of Cancer Quality of Life Group Core … treatment effect. So this is a really hot area of ongoing research right now. How do you either change the diet or …
Press release
… Chris Martin CMartin@DavidJamesGroup.com | 630-670-2745 Research Presented at the International Association for the … of 20% major pathologic response rate, according to research presented today at the International Association for … other thoracic malignancies, attracting more than 7,000 researchers, physicians and specialists from more than 100 …
Podcast
… host Dr. Narjust Duma interviews three IASLC Patient Research Advocates who are part of the IASLC Supportive Training for Advocates on Research & Science (STARS) program: Caleb Egwuenu comes from … and participated in STARS for two years as a Patient Research Advocate: Erika Hlavacek, a Patient Research …
Podcast
… including diagnosis, treatment, and new exciting research coming down the pipeline. Dr. Justin Gainor, the … Co-Leader of the SU2C Lung Cancer Dream Team. His major research interests have focused on targeted therapy and … Dr. Lizza Hendricks, Assistant Professor at research institute GROW, School for Oncology and Developmental …
Press release
… STK11 , KEAP1 or KRAS mutational status, according to research from the POSEIDON trial presented at the IASLC World … with STK11 and/or KEAP1 . Based on these findings, researchers theorized that the triplet regimen tremelimumab, … , STK11 and KEAP1 mutational status. Dr. Peters and researchers at study locations randomized 1013 patients …
Press release
… declined 43% during the COVID-19 pandemic, according to research presented today at the IASLC 2021 World Conference on … suspension of trials (60%), institutional closures (39%), research staff availability (48%), and protocol compliance … (14%),” Dr. Smeltzer said. To respond to these barriers, researchers used several strategies, including: modified …
Press release
… on Lung Cancer highlights the best in lung cancer research. Like the previous two meetings, this conference will … moderated by an IASLC member and include an IASLC Patient Research Advocate, to provide a unique perspective on how research may affect patients coping with lung cancer. Zoom …
Press release
… community including physicians, nurses, other clinicians, researchers and scientists as well as patients, survivors and … include interactive educational sessions, late-breaking research, live chats with industry and e-poster presenters, … By hosting global conferences, funding cutting-edge research and educating the health care community and the …
Press release
… platinum and pemetrexed chemotherapy alone, according to research presented today the International Association for the … (platinum and pemetrexed) or chemotherapy alone. The researchers followed patients for a median 22.4 months. … emerged after 42 months, Lim reported. Moreover, the research unveiled significant disparities in progression-free …